AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15334790
Drug: Repaglinide alone
RxNorm normalized name: Repaglinide
DrugBank: Repaglinide (DB00912)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repaglinide alone (2 mg)
Trial: 11524040
Drug: 400 i.u.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 i.u. of oral alpha-tocopherol daily for 8 weeks
Trial: 6833654
Drug: Diltiazem 180
RxNorm normalized name: diltiazem 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 180 mg/day
Trial: 9988942
Drug: Sustained-release diltiazem
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release diltiazem (120 mg twice a day)
Trial: 2082209
Drug: Oxiracetam treatment
RxNorm normalized name: oxiracetam
DrugBank: Oxiracetam (DB13601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiracetam treatment
Trial: 28224745
Drug: Supplemental oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental oxygen at a flow rate of 2 l/min
Trial: 3134446
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dimethicone and senna extract
Trial: 18809631
Drug: Alogliptin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin (both doses)
Trial: 15713945
Drug: Intravenous parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Intravenous parecoxib for at least 3 days followed by oral valdecoxib through day 10
Trial: 15713945
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo followed by oral valdecoxib
Trial: 12660054
Drug: Clindamycin 300
RxNorm normalized name: clindamycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 300 mg orally twice daily for 5 days
Trial: 29558323
Drug: Chicory leaf
RxNorm normalized name: CHICORY LEAF
DrugBank: Chicory leaf (DB14376)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chicory leaf methanolic extract capsule (1 gram, twice daily for 8 weeks)
Trial: 29558323
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule (1 gram wheat flour, twice daily for 8 weeks)
Trial: 26166797
Drug: Aflibercept therapy
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept therapy
Trial: 15125551
Drug: Subcutaneous injections
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injections
Trial: 9877014
Drug: Lorazepam (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1.2 mg PO)
Trial: 9877014
Drug: Scopolamine (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.3, 0.6 mg SC)
Trial: 9877014
Drug: Lorazepam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2 mg PO)
Trial: 27933574
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation of 400 mg of magnesium
Trial: 22907079
Drug: Nonfat milk
RxNorm normalized name: Nonfat milk
DrugBank: Skim milk (DB15546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonfat milk (500 ml daily for 2 weeks)
Trial: 22907079
Drug: Whole milk
RxNorm normalized name: Calcium fortified whole milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole milk (500 ml daily for 2 weeks)
Trial: 12768736
Drug: HBO combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBO combined with medical treatment (treatment group)
Trial: 6366151
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ESR and systemic symptoms
Trial: 25327394
Drug: Oligofructose (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligofructose (8 g/d for ages 7-11 years and 15 g/d for ages 12-18 years) for 12 weeks
Trial: 16817786
Drug: Half-dose of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose of nafamostat mesilate (NM)
Trial: 12798518
Drug: Standard two-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard two-dose Yuzpe (levonorgestrel-ethinyl estradiol)
Trial: 12798518
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of Yuzpe (levonorgestrel-ethinyl estradiol)
Trial: 12798518
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of Yuzpe
Trial: 12798518
Drug: Standard two-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard two-dose Yuzpe, Norethindrone-ethinyl estradiol, Single dose of Yuzpe
Trial: 20883736
Drug: MnCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MnCC vaccine
Trial: 10973451
Drug: Quadrivalent polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent polysaccharide vaccine
Trial: 1748257
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy
Trial: 30906944
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein supplement
Trial: 29031778
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg orally once a day for 6 years
Trial: 29031778
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg orally once a day for 3 years
Trial: 26156156
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (colectomy and adjuvant chemotherapy)
Trial: 19508679
Drug: 0.9 mg
RxNorm normalized name: estradiol 0.9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg rhTSH
Trial: 16970138
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet every other day
Trial: 16970138
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule on intervening days
Trial: 15004251
Drug: Amlodipine (calcium-channel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (calcium-channel blocker)
Trial: 15004251
Drug: Valsartan (AT1-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (AT1-receptor blocker)
Trial: 23283362
Drug: L-NMMA (NO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (NO synthase inhibitor)
Trial: 16393433
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg twice daily for 5 days
Trial: 11075941
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg once or twice daily for 7 days
Trial: 1555688
Drug: Standard hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard hormone replacement therapy (HRT) regimen
Trial: 1555688
Drug: Reduced doses
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced doses of estradiol valerate (1/3 of standard)
Trial: 1555688
Drug: Reduced doses
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced doses of progesterone (1/5 of standard)
Trial: 3930255
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg dose of UDCA
Trial: 3930255
Drug: 250, 500,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250, 500, or 750 mg doses of UDCA
Trial: 3930255
Drug: UDCA (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (various doses)
Trial: 3930255
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of UDCA
Trial: 3930255
Drug: Repeated daily
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated daily doses of UDCA
Trial: 28682933
Drug: Capsaicin (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (12 mg)
Trial: 27039236
Drug: Budesonide/Formoterol (BUD/FM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/Formoterol (BUD/FM) 320/9 μg via pressurized metered-dose inhaler (pMDI)
Trial: 20106824
Drug: Combined ramipril
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined ramipril at 10 mg/day and valsartan at 160 mg/day
Trial: 20106824
Drug: Diuretic dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic dosage uptitration
Trial: 17394248
Drug: Intracoronary administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary administration of selected CD133(+) and CD133(−) CD34(+) progenitor cells
Trial: 21475009
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (Control)
Trial: 17582923
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate (4.5 g to 9 g a day)
Trial: 17582923
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate (at least 6 g a day)
Trial: 17582923
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate (continuing treatment)
Trial: 15693087
Drug: Vitamins C
RxNorm normalized name: MULTIVITAMINS CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins C and E (500 mg vitamin C and 800 IU vitamin E daily)
Trial: 2652569
Drug: MAG (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAG (20 mg/kg/day)
Trial: 963865
Drug: Intranasal betamethasone
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal betamethasone valerate aerosol for 28 days
Trial: 963865
Drug: Oral antihistamine
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antihistamine compound
Trial: 28778464
Drug: GET 73
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GET 73 (single and repeated doses)
Trial: 24292304
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion (3 doses of 250mg/kg per dose, 24 hours apart)
Trial: 24292304
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion (3 doses, 24 hours apart)
Trial: 19624440
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (IMN) self-administered vaginally at home
Trial: 16711497
Drug: Oral analgesia
RxNorm normalized name: P-A-C Analgesic Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral analgesia (metamizole 575 mg/6 h p.o.)
Trial: 15181066
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg TU i.m.
Trial: 15181066
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 ml castor oil i.m.)
Trial: 14630678
Drug: Oral capecitabine
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral capecitabine 1250 mg/m² twice daily, days 1-14 every 21 days
Trial: 14630678
Drug: i.v. bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. bolus 5-FU 425 mg/m² with i.v. leucovorin 20 mg/m² on days 1-5, repeated every 28 days
Trial: 10468217
Drug: RRR-alpha-tocopherol 2
RxNorm normalized name: RRR-alpha-tocopheryl acetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRR-alpha-tocopherol 2 g/d combined with L-ascorbic acid 3 g/d for 50 days
Trial: 28860012
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of rocuronium (continuous-NMB-group)
Trial: 9536541
Drug: Topical lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lithium succinate ointment (Efalith), applied twice daily.
Trial: 8195977
Drug: Tc‐99m‐MDP (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tc‐99m‐MDP (20 mCi) injection and gamma-camera scanning
Trial: 27464900
Drug: Daily Practice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Practice Clothing
Trial: 6397660
Drug: Semisynthetic human
RxNorm normalized name: INSULIN,NPH,HUMAN/SEMISYNTHETIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semisynthetic human insulin (Actrapid HM, Novo)
Trial: 6397660
Drug: Purified pork
RxNorm normalized name: Insulin purified pork
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Purified pork insulin (Actrapid MC, Novo)
Trial: 6397660
Drug: Both insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both insulin preparations (HM and MC)
Trial: 19447770
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (Control)
Trial: 31479068
Drug: Open-label placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label placebo treatment for 3 weeks
Trial: 31101782
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no medical treatment)
Trial: 30246408
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy applied once a week for 8 weeks, 60 minutes per session
Trial: 23331518
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV vaccine (GARDASIL)
Trial: 18839054
Drug: PF-PPS infusions
RxNorm normalized name: PF-06459988
DrugBank: PF-06459988 (DB14768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-PPS infusions (100-100 mg/day) for 5 days
Trial: 10221723
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline infusions)
Trial: 17719763
Drug: Tiotropium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium administered via pMDI and spacer
Trial: 17719763
Drug: Tiotropium administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium administered via DPI (Rotahaler)
Trial: 15386563
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion mitoxantrone (CI-MTZ)
Trial: 15191590
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EMD and GTR
Trial: 2700237
Drug: 50% solution
RxNorm normalized name: Osmoglyn 50% Solution
DrugBank: Magnesium sulfate (DB00653)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 50% solution of dimethylsulforoxide
Trial: 911606
Drug: Enteric coated
RxNorm normalized name: Mesasal Enteric Coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric coated tablets (5 mg)
Trial: 911606
Drug: Non-enteric coated
RxNorm normalized name: diclofenac sodium (enteric coated core) 50 MG / miSOPROStol (non-enteric coated mantle) 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-enteric coated tablets (5 mg)
Trial: 22539587
Drug: Oral octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral octreotide 20 mg
Trial: 22539587
Drug: Subcutaneous (sc)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (sc) octreotide 100 μg
Trial: 17493510
Drug: Zinc +
RxNorm normalized name: GNP Cal Mag Zinc + D Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc + Oral Rehydration Solution (ORS)
Trial: 2023770
Drug: Permanent programmable
RxNorm normalized name: penicillin G benzathine Prefilled Syringe [Permapen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permanent programmable infusion pumps
Trial: 8553795
Drug: Intrathecal baclofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal baclofen infusion
Trial: 6178497
Drug: Different dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different dose fractionation irradiation schedules
Trial: 6178497
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of steroid or chemotherapy during the one‐month on‐study period
Trial: 7607932
Drug: Nicotinamide 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide 80 mg/kg/day
Trial: 7607932
Drug: Nicotinamide (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide (various doses)
Trial: 7017496
Drug: Guacetisal (preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guacetisal (preparation B)
Trial: 7017496
Drug: Bromexine, acetylsalicylic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromexine, acetylsalicylic acid, and codeine phosphate (preparation D)
Trial: 30901487
Drug: Clonidine 75
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 75 μg every third hour up to a maximum of four doses, then 75 μg twice daily until delirium free for 2 days, discharge, or a maximum of 7 days of treatment
Trial: 25623393
Drug: Intravenous golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous golimumab plus methotrexate (MTX)
Trial: 23322512
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (7,000 IU daily)
Trial: 17724802
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg/d
Trial: 16286164
Drug: Low-dose laser
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose laser
Trial: 16286164
Drug: High-dose laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose laser
Trial: 10214567
Drug: ADCON-L anti-adhesion
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADCON-L anti-adhesion barrier gel
Trial: 7783536
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg prednisone added to the current daily dose, tapering off to baseline over 18 weeks
Trial: 2215615
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 mg twice a day) and colestipol (10 g three times a day)
Trial: 2215615
Drug: Niacin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin (1 g four times a day) and colestipol (10 g three times a day)
Trial: 26695932
Drug: Twice per
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice per week (TPW) delivery of family-based childhood obesity programme
Trial: 24429536
Drug: Zinc supplements
RxNorm normalized name: Zinc Supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplements twice daily
Trial: 8657050
Drug: Low maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low maintenance doses of clozapine with concomitant neuroleptic therapy
Trial: 17426908
Drug: Methylprednisolone (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (500 mg for 5 days)
Trial: 8068956
Drug: Fractionated total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionated total body irradiation (1,320 cGy) and high-dose etoposide (60 mg/kg) followed by allogeneic bone marrow transplantation (BMT)
Trial: 3180635
Drug: Once-daily regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily regimen (2 mg phenobarbital tablet)
Trial: 8172088
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 2.5 mg (100,000 IU) cholecalciferol (vitamin D3)
Trial: 2963793
Drug: Nifedipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (5 mg three times a day rising to 20 mg three times a day)
Trial: 30653372
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy activity pacing intervention
Trial: 30653372
Drug: Typical occupational
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical occupational therapy program (control)
Trial: 26918853
Drug: Bilastine 10
RxNorm normalized name: Bilastine 10 mg orodispersible tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilastine 10 mg
Trial: 25288512
Drug: Low-dose cannabis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose cannabis (5.5 mg THC)